Luminar Tech founder devotes $70 million for new Orlando charitable fund

By: Kate Santich
Photo By: Orlando Sentinel

Austin Russell, the 26-year-old Orlando tech genius and billionaire, is plunging into the philanthropy sector with a personal donation of $70 million in stock to create a charitable fund in Central Florida — though it has yet to be determined how the money will be spent.

“This may be the biggest gift ever made in Orlando,” said Mark Brewer, president and CEO of the Central Florida Foundation, the nonprofit institution partnering with Russell to set up the fund and decide how to use it. “The reality is, this opens the door to do some really amazing things here.”

Russell, who became the world’s youngest self-made billionaire when his Luminar Technologies (LAZR) went public last year, wasn’t available for an interview Tuesday. But he released a statement saying he wanted to make a difference in the community “and beyond.”

“I established Luminar’s [headquarters] in Orlando after seeing its incredible yet underrated potential, specialized talent, community and opportunity to become a premier global technology center,” the statement reads. “I’m glad to be playing a role in realizing that vision.”

As founder and CEO of Luminar, which makes sensors for self-driving cars, Russell divides his time between Orlando and his company’s Silicon Valley offices, but his home is here. He launched the business in California in 2012 after winning a $100,000 fellowship from billionaire tech investor and PayPal co-founder Peter Thiel for his LiDAR concept, or light detection and ranging, using pulsed lasers to measure distance.

At the time, Russell was 17 and studying applied physics at Stanford. He had already attended classes at Beckman Laser Institute at the University of California, Irvine, as a high-school student. His goal, he said then, was to eradicate automobile accidents.

“When this becomes a new, modern, safety technology on vehicles that’s integrated on every vehicle globally produced, that’s when I’d firmly say that we’ve accomplished the goals that we set,” he told Forbes in December 2020.

Though Russell said in that interview he had no immediate plans for Bill Gates-like philanthropy, Brewer said Russell is interested in directing his charitable efforts toward big-picture change, as Gates has aimed to do in matters of global health.

“The work we did on homelessness a few years ago, where we had to change the entire system of how homeless people are identified and how they’re housed first, instead of after they’ve stayed in shelters for a period of time — that’s the kind of systems-level change we do and the kind of change he wants,” Brewer said. “It’s like the opioid work that’s being done here, where you’re trying to figure out how to stop the flow of people who are becoming addicted, rather than just giving them Narcan after they overdose.”

There’s no hint yet whether Russell will focus on those areas or something else entirely. In a region known for its low-wage economy and dire shortage of affordable housing, Brewer said there’s ample opportunity for Russell to make a difference. The entrepreneur will begin meeting with foundation officials by mid-January, and initial grants could be made fairly quickly, Brewer said, though he did not want to be more specific.

Jeff Hayward, president and CEO of the Heart of Florida United Way, said Russell’s move is a welcome one, especially coming from a tech entrepreneur.

“The technology sector has been less than engaging when it comes to philanthropy for critical basic needs, like helping people to keep a roof over their heads,” he said. “I’m very happy to see Mr. Russell join the fray, and I hope he’ll convince some of his peers in the community to join, too.”

Tuesday, Luminar shares traded at $17.10 on the NASDAQ, closing down 69 cents. The company projects that the market for its sensor and software solutions will reach roughly $150 billion by 2030, and it already has partnerships with eight of the world’s top 10 automakers, including a deal with Volvo Cars sealed in June to use Luminar’s technology as standard equipment on its upcoming fully electric flagship vehicle.

The Central Florida Foundation will be tasked with selling the shares overtime to make grants, and Brewer said $70 million is likely to be a starting point.

“This is just the beginning of his long-term personal commitment to philanthropy,” he said

Click here for the full article.

Who Is Austin Russell? How ‘The Next Elon Musk’ Made Billions

By: Ashley Palya

Photo by: Luminar

A new young billionaire has taken the mantle as the “world’s youngest self-made billionaire” after his self-driving technology company Luminar Technologies Inc. (LAZR) went public in December 2020. Some have taken to calling 26-year-old Austin Russell the “next Elon Musk.”

The Newport Beach, California, native applied for his first patent at 13 and worked at a laser institute at the University of California at Irvine instead of going to high school. Luminar has a market capitalization of just over $6 billion. Shares of Luminar have taken a hit in the past year. On Dec. 29, 2020, shares of Luminar closed at $32.36. On Tuesday, shares of Luminar closed at $17.10.

Click here for the full article.

Generating XACT images with a single-shot X-ray pulse in nanoseconds

By: Aili McConnon
Photo by: AIP Scilight

X-ray induced acoustic computed tomography can image the body at faster speeds and with smaller doses of radiation compared to traditional CT imaging

Siqi Wong, a graduate student in the lab of UCI Beckman Laser Institute & Medical Clinic’s Shawn Liangzhong, published a paper in Applied Physics Letters.  The paper was chosen as an Editor’s Pick and highlighted by the American Institute of Physics.

X-ray imaging is widely deployed in scientific and medical realms, but the harm of radiation and slow imaging speed remain key limitations.  Wang et al. developed a new type imaging modality called XACT (X-ray induced acoustic computed tomography) that is a promising alternative to traditional X-rays. XACT is similar to CT scans, but XACT can image the human body at a much faster speed and a much smaller radiation dose compared to traditional CT imaging.

“The innovation here is that we only need a single-shot X-ray pulse in nanoseconds to generate an XACT image, which typically requires around 1,000 pulses for averaging,” said author Siqi Wang.

The researchers used a 128-channel ring-shaped ultrasound array and a 150 kilovoltage peak X-ray source with a 50-nanosecond pulse width to achieve full tomographic imaging capability from a single pulse with a spatial resolution of 0.97 millimeters.  The team plans to develop a portable 3D X-ray fluoroscopy, which could have a large impact in interventional radiology in clinical practice.

Click here to read the full article on AIP Scilight.

Savvy New Tech, 10/6/21: Dr. Elliot Botvinick with iGlobe multianalyte sensor

I posted about Dr. Elliot Botvinick from the University of California Irvine who is developing a multianalyte sensor called iGlobe.  It is unique and exciting and funded, for development by the Leona M. and Harry B. Helmsley Charitable Trust.

Dr. Elliot Botvinick, PhD is Professor, Samueli School of Engineering, BioEngineering, Surgery, Beckman Laser Institute and Medical Clinic and The Edwards Lifesciences Center for Advanced Cardiovascular Technology. iGlobe: He was awarded a 3-year, $3.5 million grant, along with Dr. Gregory Weiss, Professor of Chemistry, from the Helmsley Charitable Trust for the development of the iGlobe, first of its kind device to simultaneously measure insulin, glucose, oxygen and ketones with a single probe inserted just beneath the skin.

Named the UCI Samueli School of Engineering “Innovator of the Year” and “Entrepreneurial Leader of the Year for several years running, Dr. Botvinick holds more than 20 invention reports and lots more than 10 patents. Dr. Botvinick earned his Ph.D., M.S., and B.S. in bioengineering from the University of California, San Diego. He’s a dynamic and very enthusiastic scientist … and he is an amazing friend to the entire T1D community.

Just this week, Dr. Botvinick did a wonderful presentation to the DIY looping community as well as those in the T1D communities.  Hope you enjoy this!

Read more on The Savvy Diabetic.

2021 UCI Innovator Awards Virtual Reception

Photo by: UCI Beall Applied Innovation

Our faculty member Dr. Anand Ganesan is nominated as a UCI Beall Applied Innovation 2021 Innovator Award Nominee in The Emerging Innovation/Early Career Innovator of the Year Award!
UCI Beall Applied Innovation, with generous support from Don and Ken Beall, created the annual UCI Innovator Awards to recognize UCI researchers working actively to promote commercialization of university intellectual property, which supports industry growth and moves inventions from the lab to market to benefit humankind.
Join us on October 19 from 1-2 p.m. PT to hear who amongst the many talented nominees will take home awards.

The Emerging Innovation/Early Career Innovator of the Year Award

Anand Ganesan, M.D. Ph.D.
Professor
School of Medicine

Han Li, Ph.D.
Associate Professor
Henry Samueli School of Engineering

Iryna Zenyuk, Ph. D.
Associate Professor
Henry Samueli School of Engineering

Click here to view the full award list on the UCI Beall Applied Innovation website.

Gratton Receives Award for Pioneering Work

The International Society for Optics and Photonics (SPIE) recognized ENRICO GRATTON with the 2021 Britton Chance Biomedical Optics Award at the SPIE Photonics West virtual conference. The award cited Gratton’s significant contributions to biophotonics – the science of producing and utilizing photons or light to image, identify and engineer biological materials. SPIE specifically noted his development of innovative ultrafast optical imaging and spectroscopy methods and their integration into microfluidic platforms.

This award was “a great honor” for Gratton who considers Chance, for whom the award was named, a “great friend.” In his conference presentation, Gratton shared his experiences meeting Chance, a National Academy of Sciences member and Olympic gold medalist in sailing who died in 2010, and doing research together.

Gratton is a professor of biomedical engineering and principal investigator for UCI’s Laboratory for Fluorescence Dynamics. A pioneer in the field of biomedical optics, Gratton’s achievements include development of the following technologies: multifrequency phase fluorometry, pulsed-source methods for frequency-domain fluorescence spectroscopy, generalized polarization to study cell membranes, spectral fluorescence lifetime measurements for cell physiology, photo-density waves, quantitative tissue oximetry with near-infrared spectroscopy and optical brain imaging.

During his more than 40-year career, Gratton has disseminated his work to researchers worldwide, trained younger scientists and interfaced successfully with industry. Under his guidance, more than 50 students have earned doctorates, with most currently occupying critical roles in academia and research institutions.

Read full article in UCI Department of Biomedical Engineering Discovery magazine.

Berns Recognized for Biomedical Optics Contributions

MICHAEL BERNS, Distinguished Professor Emeritus of biomedical engineering with a joint appointment in developmental and cell biology, and co-founder and founding director of UCI Beckman Laser Institute & Medical Clinic, has been elected as a Fellow of the Royal Society of Medicine in the United Kingdom.

Berns was invited to join the society based on his extensive biomedical optics contributions in the fields of biology and medicine. “I am truly honored to be invited to join the Royal Society, especially because it’s the same society that has honored so many elite luminaries of the past,” said Berns.

The mission of the organization is to advance health, through education and innovation. Fellows and Foreign Members of the Royal Society of Medicine are elected for life through a peer review process membership and governance. Famous Fellows include Charles Darwin, Louis Pasteur,
Edward Jenner and Sigmund Freud. Elected Fellows of the British Royal Society of Medicine are comparable to members of the National Academy of Medicine in the United States.

Click here to read UCI Department of Biomedical Engineering Discovery magazine.

Botvinick to Develop First-of-its-Kind Diabetes Monitor

Elliot Botvinick, professor of biomedical engineering, has been awarded a three-year, $3.5 million grant from The Leona M. and Harry B. Helmsley Charitable Trust to further the development of an innovative continuous-use monitor for those with Type 1 diabetes. The first-of-its kind device will simultaneously measure insulin, glucose, lactate, oxygen and the ketone body beta-hydroxybutyrate with a single probe inserted just beneath the skin.

Called iGLOBE (Insulin + Glucose + Lactate + Oxygen + Beta-HydroxybutyratE) LifeStrip, the monitor utilizes light and chemistry to provide sensing capabilities for multiple analytes, which can be critical for controlling blood glucose and detecting possible dangerous events. The device will include continuous insulin monitoring and improve dosing efficacy by providing real-time feedback on the dynamics of insulin-pump therapy as well as real-time estimates of a patient’s sensitivity to the insulin.

It is also important to monitor blood glucose in those with Type 1 diabetes, known as insulin dependent diabetes. When blood glucose is elevated above normal values, called hyperglycemia, the body produces a chemical called beta-hydroxybutyrate. Elevated beta-hydroxybutyrate is associated with diabetic ketoacidosis, a dangerous condition, which can result in hospitalization or death. iGLOBE monitors this chemical to indicate dangerous levels and ensure automated insulin delivery functions properly.

Monitoring lactate, produced during exercise, is also important, as it can indicate changing metabolic states, which can lead to changes in blood glucose hours after exercise. This will improve glucose prediction and improve insulin dosing. “Clinical evidence suggests that both beta-hydroxybutyrate and insulin sensing would improve outcomes and decrease the rates of hospitalization, severe morbidity and death associated with hypo- and hyperglycemia,” said Botvinick, who is also associate director of UCI’s Edwards Lifesciences Center for Advanced Cardiovascular Technology and professor of surgery at UCI Beckman Laser Institute (BLI).

The addition of beta-hydroxybutyrate and insulin monitoring capabilities has the potential to be life-altering. “When taken together, glucose, lactate, beta-hydroxybutyrate and insulin monitoring can transform the care of people with Type 1 diabetes,” Botvinick said. “iGLOBE can improve glucose control, compensate for glucose variations associated with exercise, inform of possible or current diabetic ketoacidosis and inform of failing or failed insulin delivery.”

Botvinick is collaborating with Gregory Weiss, UCI professor of chemistry, molecular biology and biochemistry; and David O’Neal, M.D., professor of endocrinology at Australia’s University of Melbourne. The team includes John Weidling, BLI associate project scientist, and biomedical engineering graduate students Toni Wilkinson and Dat Nguyen.

Click here to read UCI Department of Biomedical Engineering Discovery magazine.

7 New Startups Further Their Dreams in Wayfinder Program

By: Jackie Connor

Photo by: Kate Wokowsky

UC Irvine (UCI) Beall Applied Innovation’s Wayfinder incubator recently added seven new startup teams to its roster of more than 60 startups total. In addition to UCI, teams hail from across the University of California’s 10 statewide schools, including UC Berkeley, UC Riverside and UC Santa Barbara.

This new batch of startup teams are working on products and services that range from employee engagement, comedic entertainment, noninvasive devices, interactive crowdfunding and more.

StyloSonic:
Developed by UCI and UC San Diego alumni, StyloSonic is a startup that is creating a noninvasive periodontal imaging device.

Shaka:
Shaka is an employee engagement platform. This startup was also the grand prize winner in the 2021 New Venture Competition taking home $10,000 that will help accelerate their growth. UCI’s Paul Merage School of Business holds the annual competition.

Foodable:
Created by UCI undergraduates, Foodable is a platform that sells excess food at a discounted price to consumers.

Feminora:
Feminora is a startup based on UCI intellectual property that is working on a vaginal speculum that minimizes patient discomfort.

Online Open Mic:
Founded by a graduate from UCI’s Master of Innovation and Entrepreneurship program, Online Open Mic is an entertainment platform that connects comedians and fans.

Grasshopperfund:
Co-founded by UCI undergraduate students, Grasshopperfund is a crowdfunding platform that allows young entrepreneurs to highlight their startups, raise funds and find team members. The team recently placed first in the 11th annual Butterworth Product Development Competition.

Glass Notebook:
Co-founded by UCI undergraduates and alumni, Glass Notebook is a browser-based computational notebook for high-performance computer clusters.

These startups will appear in the Wayfinder program’s Pitch and Match events, which provides new and seasoned startups with a platform to pitch their company, highlight milestones and ask for guidance from community members. Stay tuned to Applied Innovation’s events.

Learn more about the Wayfinder program.

Click here to read the full article on the UCI Beall Applied Innovation website.

2021 Faculty Mentorship Awards

By: UCI School of Medicine

Congratulations to our faculty member Brian Wong for winning Clinical Faculty Mentor of the Year!

Brian Wong, MD, PhD, professor of otolaryngology, for his many years of dedication to mentoring translational and clinical faculty.

Click here to view all 2021 Faculty Mentorship Awards.